SLC6A3 and attention deficit-hyperactivity disorder: Thus, this study suggests that lower DAT availability (higher DA signaling), such as that observed in ADHD patients treated with methylphenidate, may facilitate attention by modulating brain deactivation in DMN regions (precuneus).